Notable gainers among liquid option names this morning include Insulet (PODD) $197.85 +5.27, Gilead (GILD) $78.83 +1.83, Bristol Myers Squibb (BMY) $49.25 +1.13, General Dynamics (GD) $295.66 +5.46, and Enphase Energy (ENPH) $124.56 +2.03.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD:
- Insulet: Omnipod 5 now FDA-cleared for people with Type 2 diabetes
- Street analysts say diabetes stocks âoverreactingâ to Lilly GLP-1 study results
- Diabetes stock selloff on Lilly Surmount-1 results overdone, says Citi
- Insulet opens new manufacturing facility in Malaysia
- ‘Frustrated’ JPMorgan remains buyer of Insulet after Q2 beat
